1207 related articles for article (PubMed ID: 23994726)
1. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
[TBL] [Abstract][Full Text] [Related]
2. Malignant arrhythmogenic right ventricular dysplasia/cardiomyopathy with a normal 12-lead electrocardiogram: a rare but underrecognized clinical entity.
te Riele AS; James CA; Bhonsale A; Groeneweg JA; Camm CF; Murray B; Tichnell C; van der Heijden JF; Dooijes D; Judge DP; Hauer RN; Tandri H; Calkins H
Heart Rhythm; 2013 Oct; 10(10):1484-91. PubMed ID: 23816439
[TBL] [Abstract][Full Text] [Related]
3. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Bourfiss M; Te Riele AS; Mast TP; Cramer MJ; VAN DER Heijden JF; VAN Veen TA; Loh P; Dooijes D; Hauer RN; Velthuis BK
J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1420-1428. PubMed ID: 27572111
[TBL] [Abstract][Full Text] [Related]
4. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
James CA; Bhonsale A; Tichnell C; Murray B; Russell SD; Tandri H; Tedford RJ; Judge DP; Calkins H
J Am Coll Cardiol; 2013 Oct; 62(14):1290-1297. PubMed ID: 23871885
[TBL] [Abstract][Full Text] [Related]
5. Seasonal variation in the frequency of sudden cardiac death and ventricular tachyarrhythmia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: the effect of meteorological factors.
Chung FP; Li HR; Chong E; Pan CH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Lin WY; Shaw KP; Chen SA
Heart Rhythm; 2013 Dec; 10(12):1859-66. PubMed ID: 24080066
[TBL] [Abstract][Full Text] [Related]
6. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and ventricular tachycardia.
Chu AF; Zado E; Marchlinski FE
Am J Cardiol; 2010 Sep; 106(5):720-2. PubMed ID: 20723652
[TBL] [Abstract][Full Text] [Related]
7. Clinical role of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasia.
Saguner AM; Ganahl S; Kraus A; Baldinger SH; Medeiros-Domingo A; Saguner AR; Mueller-Burri SA; Wolber T; Haegeli LM; Krasniqi N; Tanner FC; Steffel J; Brunckhorst C; Duru F
Circ J; 2014; 78(12):2854-61. PubMed ID: 25327952
[TBL] [Abstract][Full Text] [Related]
8. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia.
Piccini JP; Dalal D; Roguin A; Bomma C; Cheng A; Prakasa K; Dong J; Tichnell C; James C; Russell S; Crosson J; Berger RD; Marine JE; Tomaselli G; Calkins H
Heart Rhythm; 2005 Nov; 2(11):1188-94. PubMed ID: 16253908
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
Dalal D; Molin LH; Piccini J; Tichnell C; James C; Bomma C; Prakasa K; Towbin JA; Marcus FI; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
Circulation; 2006 Apr; 113(13):1641-9. PubMed ID: 16549640
[TBL] [Abstract][Full Text] [Related]
10. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
te Riele AS; Bhonsale A; James CA; Rastegar N; Murray B; Burt JR; Tichnell C; Madhavan S; Judge DP; Bluemke DA; Zimmerman SL; Kamel IR; Calkins H; Tandri H
J Am Coll Cardiol; 2013 Nov; 62(19):1761-9. PubMed ID: 23810894
[TBL] [Abstract][Full Text] [Related]
11. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
Schinkel AF
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
[TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.
Peters S
J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):521-6. PubMed ID: 17568286
[TBL] [Abstract][Full Text] [Related]
15. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: Prevalence, echocardiographic predictors, and treatment.
Cardona-Guarache R; Åström-Aneq M; Oesterle A; Asirvatham R; Svetlichnaya J; Marcus GM; Gerstenfeld EP; Klein L; Scheinman MM
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1801-1810. PubMed ID: 31310380
[TBL] [Abstract][Full Text] [Related]
16. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
Bhonsale A; James CA; Tichnell C; Murray B; Gagarin D; Philips B; Dalal D; Tedford R; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H
J Am Coll Cardiol; 2011 Sep; 58(14):1485-96. PubMed ID: 21939834
[TBL] [Abstract][Full Text] [Related]
17. Supraventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy associate with long-term outcome after catheter ablation of ventricular tachycardias.
Müssigbrodt A; Knopp H; Efimova E; Weber A; Bertagnolli L; Hilbert S; Kosiuk J; Dinov B; Bode K; Kircher S; Dagres N; Richter S; Sommer P; Husser D; Bollmann A; Hindricks G; Arya A
Europace; 2018 Jul; 20(7):1182-1187. PubMed ID: 28595345
[TBL] [Abstract][Full Text] [Related]
18. Premature ventricular contraction variability in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Camm CF; Tichnell C; James CA; Murray B; Porterfield F; Te Riele AS; Tandri H; Calkins H
J Cardiovasc Electrophysiol; 2015 Jan; 26(1):53-7. PubMed ID: 25215858
[TBL] [Abstract][Full Text] [Related]
19. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
[TBL] [Abstract][Full Text] [Related]
20. Early repolarization of surface ECG predicts fatal ventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and symptomatic ventricular arrhythmias.
Chan CS; Lin YJ; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Liao JN; Chen YJ; Chen SA
Int J Cardiol; 2015 Oct; 197():300-5. PubMed ID: 26148770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
